Dallas-based Colossal Biosciences made waves this week with a headline-grabbing announcement: The dire wolf is back. The startup, which calls itself the “de-extinction company,” announced ...

LONDON, UK / ACCESS Newswire / April 10, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is excited to ...

LONDON, UK / ACCESS Newswire / April 10, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is excited to ...

Additionally, it produces and sells complex specialized fermentation-based Active Pharmaceutical Ingredients (APIs), comprising probiotics, enzymes, peptides, nutritional actives, vitamin ...

Or it was – until now. The US company Colossal Biosciences claims to have revived the animal. The company from Austin in the US state of Texas calls itself “the world's only de-extinction ...

Pacific Biosciences of California (NASDAQ:PACB) stock price jumped 22% on Wednesday after the company laid down its preliminary Q1 numbers. The company expects its Q1 revenue to be $36.9M ...

In the last three months, 13 analysts have published ratings on Avidity Biosciences RNA, offering a diverse range of perspectives from bullish to bearish. The following table summarizes their ...

Texas-based firm Colossal Biosciences revealed its plans to de-extinct several other historic creatures. Genetic engineers at Colossal said the incredible process started by extracting blood cells ...

The answer, according to the Texas-based Colossal Biosciences, is a six-month-old dire wolf, a canine species that has been extinct for more than 12,000 years. But scientists have a different name ...

Colossal Biosciences says it created three wolf pups with the genes of ancient, extinct dire wolves. The startup's scientists call this "de-extinction," but other experts say these aren't dire wolves.

In a monumental scientific breakthrough, Colossal Biosciences has resurrected the long-extinct dire wolf, a majestic creature previously relegated to the realms of fantasy and popular culture ...

On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to Anixa Biosciences, Inc.'s (NASDAQ:ANIX) breast cancer vaccine technology.